|   |   | 
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/05 | |
| A61K 31/185 | |||
| A61K 31/352 | |||
| A61P 25/16 | |||
| A61P 25/28 | |||
| A61P 25/00 | |||
| A61P 9/10 | 
| (11) | Number of the document | 2726069 | 
| (13) | Kind of document | T | 
| (96) | European patent application number | 12731151.2 | 
| Date of filing the European patent application | 2012-06-29 | |
| (97) | Date of publication of the European application | 2014-05-07 | 
| (45) | Date of publication and mention of the grant of the patent | 2019-05-01 | 
| (46) | Date of publication of the claims translation | 
| (86) | Number | PCT/GB2012/051540 | 
| Date | 2012-06-29 | 
| (87) | Number | WO 2013/005017 | 
| Date | 2013-01-10 | 
| (30) | Number | Date | Country code | 
| 201111261 | 2011-07-01 | GB | 
| (72) | 
                    
                    
                    
                    
                    IUVONE, Teresa, IT  
                    
                    
                    
                    
                    DI MARZO, Vincenzo, IT  
                    
                    
                    
                    
                    GUY, Geoffrey, GB  
                    
                    
                    
                    
                    WRIGHT, Stephen, GB  
                    
                    
                    
                    
                    STOTT, Colin, GB  | 
| (73) | GW Pharma Limited,
                Sovereign House, Histon  Cambridge CB24 9BZ,
                GB | 
| (54) | CANNABINOIDS FOR USE IN THE TREATMENT OF NEURODEGENERATIVE DISEASES OR DISORDERS | 
| CANNABINOIDS FOR USE IN THE TREATMENT OF NEURODEGENERATIVE DISEASES OR DISORDERS |